The GLP-1 Forecast for 2024: Six Key Predictions

The GLP-1 Forecast for 2024: Six Key Predictions

While GLP-1 medicines can be game changers in the management of obesity, we anticipate that they will also trigger a huge wave of cost increases for employers, payors, and our entire health system. This white paper identifies six GLP-1 trends for the upcoming year and corresponding takeaways for employers looking to craft a proactive utilization and care management approach.

Download the report today to find key recommendations for employers including:

  • Find programs anchored to behavior and lifestyle change to help employees maintain weight loss and reduce long-term medication dependency
  • Offer workforces a full-spectrum approach from prevention to clinical treatment
  • Identify partners who invest in long-term studies to test the efficacy of their care models

    Do you have oversight into your company's employee benefits program?

    All information that you supply is protected by our Privacy Policy.
    In order to provide you with this free service, we may share your business information with companies whose content you choose to view on this website.
    By submitting your information you agree to our Terms of Use.
    Third party cookies may be placed, to serve more relevant ads when you browse the web.
    You can learn more about those ads here.